Pavlidis N - Search Results

1

New rising entities in cancer of unknown primary: Is there a real therapeutic benefit?

Rassy E, Parent P, Lefort F, Boussios S, Baciarello G, Pavlidis N. Rassy E, et al. Among authors: pavlidis n. Crit Rev Oncol Hematol. 2020 Mar;147:102882. doi: 10.1016/j.critrevonc.2020.102882. Epub 2020 Jan 23. Crit Rev Oncol Hematol. 2020. PMID: 32106012 Review.

2

Chemotherapy for patients with two favourable subsets of unknown primary carcinoma: active, but how effective?

Pentheroudakis G, Briasoulis E, Karavassilis V, Fountzilas G, Xeros N, Samelis G, Samantas E, Pavlidis N. Pentheroudakis G, et al. Among authors: pavlidis n. Acta Oncol. 2005;44(2):155-60. doi: 10.1080/02841860510029554. Acta Oncol. 2005. PMID: 15788295

3

Cancer of unknown primary (CUP).

Pavlidis N, Fizazi K. Pavlidis N, et al. Crit Rev Oncol Hematol. 2005 Jun;54(3):243-50. doi: 10.1016/j.critrevonc.2004.10.002. Crit Rev Oncol Hematol. 2005. PMID: 15890271 Review.

4

Brain metastasis of unknown primary: a diagnostic and therapeutic dilemma.

Polyzoidis KS, Miliaras G, Pavlidis N. Polyzoidis KS, et al. Among authors: pavlidis n. Cancer Treat Rev. 2005 Jun;31(4):247-55. doi: 10.1016/j.ctrv.2005.03.006. Cancer Treat Rev. 2005. PMID: 15913895 Review.

5

Matrix metalloproteinases in carcinoma of unknown primary.

Karavasilis V, Malamou-Mitsi V, Briasoulis E, Tsanou E, Kitsou E, Kalofonos H, Fountzilas G, Fotsis T, Pavlidis N. Karavasilis V, et al. Among authors: pavlidis n. Cancer. 2005 Nov 15;104(10):2282-7. doi: 10.1002/cncr.21454. Cancer. 2005. PMID: 16220559 Free article.

6

Perspectives for targeted therapies in cancer of unknown primary site.

Pentheroudakis G, Pavlidis N. Pentheroudakis G, et al. Among authors: pavlidis n. Cancer Treat Rev. 2006 Dec;32(8):637-44. doi: 10.1016/j.ctrv.2006.08.004. Cancer Treat Rev. 2006. PMID: 17046164 Review.

7

Cancer of unknown primary site: missing primary or missing biology?

Pentheroudakis G, Briasoulis E, Pavlidis N. Pentheroudakis G, et al. Among authors: pavlidis n. Oncologist. 2007 Apr;12(4):418-25. doi: 10.1634/theoncologist.12-4-418. Oncologist. 2007. PMID: 17470684 Free article. Review.

8

Forty years experience of treating cancer of unknown primary.

Pavlidis N. Pavlidis N. Acta Oncol. 2007;46(5):592-601. doi: 10.1080/02841860701243095. Acta Oncol. 2007. PMID: 17562435 Review.

9

Switching benchmarks in cancer of unknown primary: from autopsy to microarray.

Pentheroudakis G, Golfinopoulos V, Pavlidis N. Pentheroudakis G, et al. Among authors: pavlidis n. Eur J Cancer. 2007 Sep;43(14):2026-36. doi: 10.1016/j.ejca.2007.06.023. Epub 2007 Aug 14. Eur J Cancer. 2007. PMID: 17698346

10

Integrating trastuzumab in the neoadjuvant treatment of primary breast cancer: accumulating evidence of efficacy, synergy and safety.

Lazaridis G, Pentheroudakis G, Pavlidis N. Lazaridis G, et al. Among authors: pavlidis n. Crit Rev Oncol Hematol. 2008 Apr;66(1):31-41. doi: 10.1016/j.critrevonc.2007.07.002. Epub 2007 Sep 4. Crit Rev Oncol Hematol. 2008. PMID: 17766143 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

491 results

Search Page